Trial no.:
|
PACTR201703002081320 |
Date of Approval:
|
07/03/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Transversus Abdominis Plane Block levobupivacaine plus ketamine in abdominoplasty |
Official scientific title |
Transversus Abdominis Plane Block ¿TAP¿: A Comparative Study between levobupivacaine versus levobupivacaine plus ketamine in abdominoplasty |
Brief summary describing the background
and objectives of the trial
|
Abdominoplasty is a major cosmetic surgery with a painful post operative period. Recently more and more anaesthetists are turning to regional analgesia for anterior abdominal wall surgery namely the Transversus Abdominis Plane (TAP) Block with or without ultrasound guidance.
Transversus abdominis plane (TAP) block was first described by Rafi in 2001, provides analgesia to the anterolateral abdominal wall by injecting local anesthesia into the plane between the internal oblique and transversus abdominis muscle and thus giving pain relief.
TAP block has been found to be a safe and effective tool in a variety of general, gynecological, urological, plastic, and pediatric surgeries, and it is suggested as part of the multimodal anesthetic approach to enhance recovery after lower abdominal surgeries.
Local diffusion into the TAP requires a large volume of anaes¬thetic to determine the effective spread on interested nerves: all authors suggested a median volume of 15-20 ml of anaesthetic for each puncture and this raises the issue of potentially toxic plasma concentrations of the local anaesthetic.
The addition of ketamine to a local anesthetic or other analgesics in peripheral or neuraxial anesthesia and analgesia improves or prolongs pain relief. A decrease in drug-related side effects (sedation, pruritus, or adverse psychological reactions) has also been found, mainly because the required drug doses could be reduced. These effects may relate to blockade of central and peripheral NMDA receptors and/or an antinociceptive action complementary to that of the other drugs used. Central and peripheral sensitization may thus be prevented.
Aim of the work
The aim of this study to compare the effectiveness of adding ketamine to levobupivacaine in TAB in patient undergoing abdominoplasty.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,perio-perative analgesia,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/06/2016 |
Actual trial start date |
01/08/2016 |
Anticipated date of last follow up |
01/06/2017 |
Actual Last follow-up date |
01/06/2017 |
Anticipated target sample size (number of participants) |
50 |
Actual target sample size (number of participants) |
50 |
Recruitment status |
Recruiting |
Publication URL |
|
|